| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.5 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.5 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |